MBP metabolic pharmaceuticals limited

back on the radar, page-19

  1. 970 Posts.
    Yes IMI looks interesting, but will fall to about half current levels. Only then would it be a good buy .With the Gov spending billions on health as an election sweetner this is bound to go up, but it is to expensive at present.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.